by admin | May 26, 2015 | Publications
Progressive multifocal leukoencephalopathy (PML) is a deadly demyelinating disease of the brain, caused by reactivation of the polyomavirus JC (JCV). PML has classically been described in individuals with profound cellular immunosuppression such as patients with AIDS,... by admin | May 26, 2015 | Publications
Background: Raltegravir (RAL) is a novel drug and first of the HIV integrase inhibitor class, gaining US market approval in October 2007. The current study evaluates the real world utilization patterns of RAL within the OPERA Clinical database. Methods: The analysis... by admin | May 26, 2015 | Publications
Studies of injectable poly-L-lactic acid (PLLA) in human immunodeficiency virus (HIV)-associated facial lipoatrophy have predominantly included male Caucasians. To report cumulative year 2 interim study results examining the safety and efficacy of injectable PLLA in... by admin | May 26, 2015 | Publications
Patients virologically suppressed on TDF/FTC + ATV/r may require alternative regimens that maintain suppression while addressing some drug-related side effects. We explored two alternative regimens that replace RTV and/or TDF/FTC. This open-label exploratory pilot... 
by admin | May 26, 2015 | News, Press
An award winning and board-certified physician, Dr. Gerald Pierone is a tried and true leader in the field of facial rejuvenation. Dr. Pierone has performed over 2,000 procedures using dermal fillers with results so outstanding he has been asked by both Radiesse® and...